Database.xlsx

Database for the article "Screening patients with metastatic breast cancer for psychiatric disease: a cross sectional study". We conducted a cross-sectional, single-center study.
The convenience sample was designed with inclusion criteria consisting of female
patients 18 years of age or older, diagnosed with metastatic breast carcinoma
under palliative treatment with chemotherapy, hormone therapy, cyclin
inhibitors, or targeted anti-HER2 therapy, between November 2020 and May 2021,
at the Medical Oncology Department of the Instituto Português de
Oncologia de Coimbra Francisco Gentil, E.P.E. Exclusion criteria for the study were known brain
metastasis, baseline cognitive impairment, refusal to participate in the study,
and incomplete clinical records. The final sample size after included 91 of the
initial 128 participants evaluated.

Patients were recruited at
the outpatient daycare unit when they were present for treatment. The
application and filling-out of the various scales (Mini Mental State Examination (MMSE), HADS, BSI, and WHOQoL-Bref instruments) was conducted by the
first author before treatment in order to minimize bias that could be developed
in the post-treatment period. MMSE was the first instrument to be used, since a
score compatible with cognitive impairment would represent and exclusion
criteria. Afterwards, HADS, BSI and
WHOQoL-Bref scales were applied through direct questioning of the patients and
presentation of various possibilities of response, with repetition of each if
solicited. The referral for the Psychiatry appointment was made whenever the
HADS scale exceeded the cut-off score of 8 in each part of the instrument [17]
or when the BSI exceeded the cut-off of 1.7 [18, 19]. The referred patients
were posteriorly evaluated by an element of the psychiatric team consisting of
two specialists, ideally within a month after the application of scales and at
times within a week if the screening determined an elevated psychopathological
risk. Determinants of elevated risk or severity included suicidal ideation and
depressive symptoms with significant impact on daily functioning. The results,
including possible diagnoses and eventual necessity of psychiatric medication
from this evaluation were determined at this observation. The codification of psychiatric diagnoses was
carried out using the International Classification of Diseases, Tenth Revision
(ICD-10).

The
following complementary data were collected either by direct questioning of the
patient or consultation of the electronic files: gender; age; Eastern
Cooperative Oncology Group – Performance Status (ECOG-PS); gynecological
history; obstetric history; psychiatric; social history and characteristics of
oncological disease.